Home/ Stocks/ BJDX

Bluejay Diagnostics, Inc. Common Stock

BJDX XNAS

$4.89 +0.10 (+2.11%) ▲ 15-min delayed

Open

$4.69

High

$4.93

Low

$4.52

Volume

62.8K

Market Cap

$4.90M

About Bluejay Diagnostics, Inc. Common Stock

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 6 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-1,919,241	$-1.95
FY 2025	$0	$-6,848,483	$-15.25
Q3 2025	$0	$-1,597,632	$-1.01
Q2 2025	$0	$-1,956,604	$-1.41

TickerDaily Coverage

Why Is Bluejay Diagnostics, Inc. Common Stock (BJDX) Stock Up 177.5% Today?

Market News Alex Chen · Jun 2, 2026

Bluejay Diagnostics stock exploded higher Tuesday after the company announced an abstract...

Stock Market Today, June 5, 2026: Micro-Caps Surge on Speculation Wave

Market News David Brooks · 6d ago

Micro-cap and penny stocks dominated trading on Friday, June 5, 2026, with eight securities posting...

View All Coverage →

Get BJDX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Bluejay Diagnostics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.